Post Profile






Diabetes Advocates Protest at Eli Lilly About Insulin Prices

On Saturday, September 9th, 2017 a group of diabetes patient advocates organized by T1International and People of Faith for Access to Medicines (PFAM) showed up in front of Eli Lilly’s Headquarters in Indianapolis, Indiana to protest rising insulin prices. Eli Lilly is one of the three top insulin manufacturers. The company markets Basaglar, Glucagon, Humalog, […]
read more

share

Related Posts


Lilly Diabetes Summit Sequel: A Peek at Insulin Giant’s Workings

Diseases & Conditions / Diabetes : Diabetes Mine

Last week, for the second year in a row, I attended the Lilly Diabetes Blogger Summit in Indianapolis and experienced up close and personal the place that’s been making the insulin that’s been keeping me alive for almost 30 years.… ...

Lilly (Finally) Engages the Diabetes Patient Community

Diseases & Conditions / Diabetes : Diabetes Mine

When I heard that Lilly Diabetes was holding its first-ever Diabetes Blogger Summit, my initial thought was: “It’s about flippin’ time.” I’m an active patient advocate and blogger who’s lived in Indianapolis for close to a decade an...

Guest Post: People with Diabetes are Demonstrating for #insulin4all

Diseases & Conditions / Diabetes : Six Until Me

Today’s guest post comes from Elizabeth Rowley, director of T1International – an organization working towards sustainable access and affordability of insulin, diabetes supplies, medical care and education for all people living with ...

Cost of Insulin to Decrease for Some as Eli Lilly Offers Discounts

Diseases & Conditions / Diabetes : Diabetes Self-Management

The cost of insulin from Eli Lilly will decrease for those using an online discount platform that will be available starting on January 1, 2017... The post Cost of Insulin to Decrease for Some as Eli Lilly Offers Discounts appeared ...

Eli Lilly announces insulin discount after years of price hikes

Health : Chicago Tribune: Health

Under pressure from politicians and patient groups, diabetes pharmaceutical giants have been taking action in recent weeks to limit the effect of rising insulin prices on patients. On Tuesday, Eli Lilly and Co. announced that, start...

Comments


Copyright © 2016 Regator, LLC